Principal Financial Group
IRWD icon

Principal Financial Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Principal Financial Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.9K Buy
+11,375
New +$46.6K ﹤0.01% 2155
2025
Q4 		– Sell
-12,600
Closed -$16.5K – 2232
2025
Q3 		$16.5K Sell
12,600
-176,464
-93% -$183K ﹤0.01% 2242
2025
Q2 		$136K Buy
189,064
+96,682
+105% +$75.9K ﹤0.01% 2153
2025
Q1 		$136K Sell
92,382
-672,974
-88% -$1.6M ﹤0.01% 2081
2024
Q4 		$3.39M Buy
765,356
+29,629
+4% +$120K ﹤0.01% 1695
2024
Q3 		$3.03M Sell
735,727
-59,598
-7% -$320K ﹤0.01% 1698
2024
Q2 		$5.19M Sell
795,325
-9,575
-1% -$67.7K ﹤0.01% 1545
2024
Q1 		$7.01M Buy
804,900
+3,120
+0.4% +$37.9K ﹤0.01% 1462
2023
Q4 		$9.17M Sell
801,780
-69
-0% -$683 0.01% 1325
2023
Q3 		$7.72M Sell
801,849
-6,708
-0.8% -$65.7K 0.01% 1352
2023
Q2 		$8.6M Sell
808,557
-40,560
-5% -$436K 0.01% 1319
2023
Q1 		$8.93M Sell
849,117
-24,325
-3% -$272K 0.01% 1320
2022
Q4 		$10.8M Sell
873,442
-51,001
-6% -$579K 0.01% 1197
2022
Q3 		$9.58M Sell
924,443
-303,360
-25% -$3.44M 0.01% 1212
2022
Q2 		$14.2M Buy
1,227,803
+972,231
+380% +$11.5M 0.01% 1070
2022
Q1 		$3.21M Sell
255,572
-104,097
-29% -$1.19M ﹤0.01% 1788
2021
Q4 		$4.19M Buy
359,669
+9,059
+3% +$111K ﹤0.01% 1727
2021
Q3 		$4.58M Buy
350,610
+15,829
+5% +$205K ﹤0.01% 1718
2021
Q2 		$4.31M Buy
334,781
+54,101
+19% +$619K ﹤0.01% 1753
2021
Q1 		$3.14M Buy
280,680
+12,499
+5% +$132K ﹤0.01% 1777
2020
Q4 		$3.05M Sell
268,181
-51,659
-16% -$565K ﹤0.01% 1706
2020
Q3 		$2.88M Buy
319,840
+119,397
+60% +$1.19M ﹤0.01% 1648
2020
Q2 		$2.07M Buy
200,443
+156,987
+361% +$1.61M ﹤0.01% 1693
2020
Q1 		$438K Buy
43,456
+413
+1% +$4.85K ﹤0.01% 1882
2019
Q4 		$573K Sell
43,043
-9,134
-18% -$101K ﹤0.01% 1917
2019
Q3 		$448K Buy
52,177
+4,560
+10% +$44.3K ﹤0.01% 1968
2019
Q2 		$521K Sell
47,617
-303
-0.6% -$3.39K ﹤0.01% 1954
2019
Q1 		$543K Buy
47,920
+2,013
+4% +$22.5K ﹤0.01% 1916
2018
Q4 		$398K Sell
45,907
-10,929
-19% -$125K ﹤0.01% 1964
2018
Q3 		$879K Buy
56,836
+8,154
+17% +$129K ﹤0.01% 1867
2018
Q2 		$779K Sell
48,682
-2,461
-5% -$36.4K ﹤0.01% 1886
2018
Q1 		$661K Sell
51,143
-263
-0.5% -$3.28K ﹤0.01% 1897
2017
Q4 		$645K Sell
51,406
-53,978
-51% -$705K ﹤0.01% 1918
2017
Q3 		$1.39M Sell
105,384
-2,699
-2% -$37.1K ﹤0.01% 1782
2017
Q2 		$1.71M Buy
108,083
+79,366
+276% +$1.15M ﹤0.01% 1762
2017
Q1 		$410K Buy
28,717
+74
+0.3% +$1.01K ﹤0.01% 1949
2016
Q4 		$367K Buy
28,643
+1,151
+4% +$14.5K ﹤0.01% 1978
2016
Q3 		$366K Buy
27,492
+306
+1% +$3.58K ﹤0.01% 1912
2016
Q2 		$298K Buy
27,186
+680
+3% +$6.64K ﹤0.01% 1944
2016
Q1 		$243K Buy
26,506
+540
+2% +$4.45K ﹤0.01% 1976
2015
Q4 		$252K Buy
25,966
+525
+2% +$5.07K ﹤0.01% 1991
2015
Q3 		$222K Sell
25,441
-483
-2% -$4.51K ﹤0.01% 2006
2015
Q2 		$262K Sell
25,924
-515
-2% -$5.99K ﹤0.01% 1985
2015
Q1 		$354K Buy
26,439
+3,398
+15% +$44.6K ﹤0.01% 1883
2014
Q4 		$296K Sell
23,041
-6,656
-22% -$76.2K ﹤0.01% 1929
2014
Q3 		$322K Hold
29,697
– – ﹤0.01% 1905
2014
Q2 		$381K Sell
29,697
-884
-3% -$9.61K ﹤0.01% 1904
2014
Q1 		$316K Sell
30,581
-290
-0.9% -$3.26K ﹤0.01% 1972
2013
Q4 		$300K Hold
30,871
– – ﹤0.01% 1994
2013
Q3 		$306K Sell
30,871
-6,030
-16% -$59.2K ﹤0.01% 1957
2013
Q2 		$308K Buy
+36,901
New +$447K ﹤0.01% 1932

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Principal Financial Group's IRWD Position: Q1 2026 in Review

Principal Financial Group opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 11,375 shares worth $39.9K. The stake represents ﹤0.01% of the portfolio and ranks #2155 among its holdings. This is a return to the name: Principal Financial Group previously reported a position in IRWD as recently as Q3 2025.

Principal Financial Group first reported a position in IRWD in Q2 2013 and has held it in 51 quarters since. The position peaked at $14.2M in Q2 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Principal Financial Group held 11,375 shares of Ironwood Pharmaceuticals worth $39.9K as of Q1 2026.
  • Ironwood Pharmaceuticals was a new Principal Financial Group position in Q1 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Principal Financial Group's portfolio in Q1 2026, its #2155 holding.
  • Principal Financial Group first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
  • Principal Financial Group's Ironwood Pharmaceuticals position peaked at $14.2M in Q2 2022.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Principal Financial Group's 13F filing for Q1 2026, filed 4 May 2026.